Oct-2021 Evolution of Endpoints: The Changing Paradigm in Trials for Active UC (by Prof. Travis) Managing Active UC Flares with Second Generation Corticosteroid: Real World Experience (by Prof. Leung)

Medihub

Oct-2021 Evolution of Endpoints: The Changing Paradigm in Trials for Active UC (by Prof. Travis) Managing Active UC Flares with Second Generation Corticosteroid: Real World Experience (by Prof. Leung)

Speakers:

Professor Simon Travis, Translational Gastroenterology Unit and Linacre College, Oxford, UK

Professor WK Leung, The University of Hong Kong, Hong Kong

In this recording, IBD experts from UK, HK and India shared their view and clinical experience in using either topical or systemic corticosteroid in managing active UC. The role of second generation corticosteroids was discussed among panelists regarding the selection of patients and the treatment strategy.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK